Eli Lilly and Company revenue breakdown overview

Eli Lilly and Company revenue for the last year amounted to 45.04 B USD, the most of which — 45.04 B USD — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 34.12 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Eli Lilly and Company 30.38 B USD, and the year before that — 21.79 B USD.